+91-22-489139092019 کے بہترین ایکویٹی باہمی فنڈز
ایکویٹی فنڈز وہی ہیں جن کے جمع شدہ فنڈ کی رقم مختلف کمپنیوں کے ایکویٹی اور ایکوئٹی سے متعلقہ آلات میں لگائی جاتی ہے۔ ایکویٹی فنڈز اعتدال پسند اور اعلی افراد والے افراد کے لئے طویل مدتی سرمایہ کاری کا اختیار سمجھا جاتا ہےخطرہ بھوک. ایکویٹی فنڈز کی مختلف اقسام میں شامل ہیںبڑے ٹوپی فنڈز،مڈ کیپ فنڈز،سمال ٹوپی فنڈز،ای ایل ایس ایس، اور اسی طرح. سال 2019 میں ، ایکویٹی منڈیوں میں اضافہ دیکھا گیا جس کی وجہ سے اکثر ایکویٹی فنڈ کیٹیگریز نے عمدہ کارکردگی کا مظاہرہ کیا۔ ان فنڈز کی کارکردگی کا انحصار بہت سارے میکرو اور مائیکرو اکنامک پیرامیٹرز جیسے صنعت کی کارکردگی ، کمپنی کی کارکردگی ، کمپنیوں کی کمائی اور منافع ، اس کی مستقبل کی صلاحیتوں وغیرہ پر ہے۔ سب سے اوپر اورایکویٹی کے بہترین فنڈز سال 2019 کے لئے مندرجہ ذیل ہیں۔
Talk to our investment specialist
کارکردگی کی بنیاد پر 2019 کے سب سے اوپر 10 ایکویٹی باہمی فنڈز
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) Motilal Oswal Midcap 30 Fund Growth ₹101.72
↑ 0.52 ₹33,053 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹48.134
↓ -0.39 ₹1,053 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹50.2812
↓ -0.14 ₹4,506 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹60.6801
↑ 0.33 ₹13,894 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹179.51
↑ 0.03 ₹7,406 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹294.793
↓ -0.28 ₹1,099 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹432.903
↑ 5.22 ₹3,849 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹31.0352
↓ -0.10 ₹1,282 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹29.1101
↓ -0.08 ₹605 40 33.4 2.4 64.7 19 Bandhan Infrastructure Fund Growth ₹48.965
↓ -0.41 ₹1,749 39.3 50.3 1.7 64.8 6.3 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 14 Aug 25 Research Highlights & Commentary of 10 Funds showcased
Commentary Motilal Oswal Midcap 30 Fund LIC MF Infrastructure Fund Motilal Oswal Long Term Equity Fund Motilal Oswal Multicap 35 Fund Invesco India Mid Cap Fund UTI Healthcare Fund SBI Healthcare Opportunities Fund TATA India Pharma & Healthcare Fund IDBI Small Cap Fund Bandhan Infrastructure Fund Point 1 Highest AUM (₹33,053 Cr). Bottom quartile AUM (₹1,053 Cr). Upper mid AUM (₹4,506 Cr). Top quartile AUM (₹13,894 Cr). Upper mid AUM (₹7,406 Cr). Bottom quartile AUM (₹1,099 Cr). Upper mid AUM (₹3,849 Cr). Lower mid AUM (₹1,282 Cr). Bottom quartile AUM (₹605 Cr). Lower mid AUM (₹1,749 Cr). Point 2 Established history (11+ yrs). Established history (17+ yrs). Established history (10+ yrs). Established history (11+ yrs). Established history (18+ yrs). Oldest track record among peers (26 yrs). Established history (20+ yrs). Established history (9+ yrs). Established history (8+ yrs). Established history (14+ yrs). Point 3 Rating: 3★ (upper mid). Not Rated. Not Rated. Top rated. Rating: 2★ (upper mid). Rating: 1★ (lower mid). Rating: 2★ (upper mid). Not Rated. Not Rated. Rating: 5★ (top quartile). Point 4 Risk profile: Moderately High. Risk profile: High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: Moderately High. Risk profile: High. Risk profile: High. Risk profile: High. Risk profile: Moderately High. Risk profile: High. Point 5 5Y return: 33.64% (top quartile). 5Y return: 31.35% (upper mid). 5Y return: 25.26% (lower mid). 5Y return: 18.78% (bottom quartile). 5Y return: 28.53% (upper mid). 5Y return: 19.00% (bottom quartile). 5Y return: 20.46% (lower mid). 5Y return: 19.10% (bottom quartile). 5Y return: 28.11% (upper mid). 5Y return: 32.50% (top quartile). Point 6 3Y return: 27.87% (top quartile). 3Y return: 27.04% (upper mid). 3Y return: 24.16% (lower mid). 3Y return: 22.33% (bottom quartile). 3Y return: 27.67% (upper mid). 3Y return: 25.70% (lower mid). 3Y return: 26.84% (upper mid). 3Y return: 23.78% (bottom quartile). 3Y return: 17.27% (bottom quartile). 3Y return: 27.68% (top quartile). Point 7 1Y return: 3.43% (lower mid). 1Y return: -3.81% (bottom quartile). 1Y return: 1.00% (lower mid). 1Y return: 7.25% (upper mid). 1Y return: 15.29% (top quartile). 1Y return: 11.23% (upper mid). 1Y return: 11.62% (top quartile). 1Y return: 4.82% (upper mid). 1Y return: -8.42% (bottom quartile). 1Y return: -10.07% (bottom quartile). Point 8 Alpha: 3.89 (upper mid). Alpha: 0.77 (lower mid). Alpha: 6.93 (top quartile). Alpha: 8.72 (top quartile). Alpha: 0.00 (bottom quartile). Alpha: 1.14 (lower mid). Alpha: 2.79 (upper mid). Alpha: 2.42 (upper mid). Alpha: -7.27 (bottom quartile). Alpha: 0.00 (bottom quartile). Point 9 Sharpe: 0.23 (lower mid). Sharpe: -0.02 (bottom quartile). Sharpe: 0.26 (lower mid). Sharpe: 0.42 (upper mid). Sharpe: 0.54 (upper mid). Sharpe: 0.75 (top quartile). Sharpe: 0.87 (top quartile). Sharpe: 0.47 (upper mid). Sharpe: -0.27 (bottom quartile). Sharpe: -0.29 (bottom quartile). Point 10 Information ratio: 0.44 (upper mid). Information ratio: 0.45 (upper mid). Information ratio: 1.02 (top quartile). Information ratio: 0.73 (top quartile). Information ratio: 0.00 (lower mid). Information ratio: -0.29 (bottom quartile). Information ratio: 0.37 (lower mid). Information ratio: 0.73 (upper mid). Information ratio: -0.92 (bottom quartile). Information ratio: 0.00 (bottom quartile). Motilal Oswal Midcap 30 Fund
LIC MF Infrastructure Fund
Motilal Oswal Long Term Equity Fund
Motilal Oswal Multicap 35 Fund
Invesco India Mid Cap Fund
UTI Healthcare Fund
SBI Healthcare Opportunities Fund
TATA India Pharma & Healthcare Fund
IDBI Small Cap Fund
Bandhan Infrastructure Fund
2019 کے سب سے اوپر اور بہترین ایکویٹی باہمی فنڈز
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. Research Highlights for LIC MF Infrastructure Fund Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Research Highlights for Motilal Oswal Long Term Equity Fund Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Research Highlights for Motilal Oswal Multicap 35 Fund Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Research Highlights for Invesco India Mid Cap Fund Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. Research Highlights for UTI Healthcare Fund Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. Research Highlights for SBI Healthcare Opportunities Fund Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. Research Highlights for TATA India Pharma & Healthcare Fund Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. Research Highlights for IDBI Small Cap Fund Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. Research Highlights for Bandhan Infrastructure Fund Below is the key information for Bandhan Infrastructure Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (14 Aug 25) ₹101.72 ↑ 0.52 (0.52 %) Net Assets (Cr) ₹33,053 on 30 Jun 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 0.23 Information Ratio 0.44 Alpha Ratio 3.89 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Aug 25 Duration Returns 1 Month -0.7% 3 Month 2.8% 6 Month 8.6% 1 Year 3.4% 3 Year 27.9% 5 Year 33.6% 10 Year 15 Year Since launch 22.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 57.1% 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Data below for Motilal Oswal Midcap 30 Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 2. LIC MF Infrastructure Fund
LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (14 Aug 25) ₹48.134 ↓ -0.39 (-0.80 %) Net Assets (Cr) ₹1,053 on 30 Jun 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio -0.02 Information Ratio 0.45 Alpha Ratio 0.77 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Aug 25 Duration Returns 1 Month -3.5% 3 Month 6.8% 6 Month 14.4% 1 Year -3.8% 3 Year 27% 5 Year 31.4% 10 Year 15 Year Since launch 9.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Data below for LIC MF Infrastructure Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 3. Motilal Oswal Long Term Equity Fund
Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (14 Aug 25) ₹50.2812 ↓ -0.14 (-0.28 %) Net Assets (Cr) ₹4,506 on 30 Jun 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 0.74 Sharpe Ratio 0.26 Information Ratio 1.02 Alpha Ratio 6.93 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value Returns for Motilal Oswal Long Term Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Aug 25 Duration Returns 1 Month -4.3% 3 Month 4.9% 6 Month 11.6% 1 Year 1% 3 Year 24.2% 5 Year 25.3% 10 Year 15 Year Since launch 16.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.7% 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Data below for Motilal Oswal Long Term Equity Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 4. Motilal Oswal Multicap 35 Fund
Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (14 Aug 25) ₹60.6801 ↑ 0.33 (0.55 %) Net Assets (Cr) ₹13,894 on 30 Jun 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 0.94 Sharpe Ratio 0.42 Information Ratio 0.73 Alpha Ratio 8.72 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Motilal Oswal Multicap 35 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Aug 25 Duration Returns 1 Month -3% 3 Month 1.4% 6 Month 8.3% 1 Year 7.2% 3 Year 22.3% 5 Year 18.8% 10 Year 15 Year Since launch 17.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 45.7% 2023 31% 2022 -3% 2021 15.3% 2020 10.3% 2019 7.9% 2018 -7.8% 2017 43.1% 2016 8.5% 2015 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Data below for Motilal Oswal Multicap 35 Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 5. Invesco India Mid Cap Fund
Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (14 Aug 25) ₹179.51 ↑ 0.03 (0.02 %) Net Assets (Cr) ₹7,406 on 30 Jun 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.89 Sharpe Ratio 0.54 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Invesco India Mid Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Aug 25 Duration Returns 1 Month -0.3% 3 Month 10.3% 6 Month 20.6% 1 Year 15.3% 3 Year 27.7% 5 Year 28.5% 10 Year 15 Year Since launch 17.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% 2015 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Data below for Invesco India Mid Cap Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 6. UTI Healthcare Fund
UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (14 Aug 25) ₹294.793 ↓ -0.28 (-0.09 %) Net Assets (Cr) ₹1,099 on 30 Jun 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.75 Information Ratio -0.29 Alpha Ratio 1.14 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Aug 25 Duration Returns 1 Month 2.4% 3 Month 9.4% 6 Month 11.9% 1 Year 11.2% 3 Year 25.7% 5 Year 19% 10 Year 15 Year Since launch 15.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Data below for UTI Healthcare Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 7. SBI Healthcare Opportunities Fund
SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (13 Aug 25) ₹432.903 ↑ 5.22 (1.22 %) Net Assets (Cr) ₹3,849 on 30 Jun 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.87 Information Ratio 0.37 Alpha Ratio 2.79 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Aug 25 Duration Returns 1 Month 0.1% 3 Month 4.3% 6 Month 6.5% 1 Year 11.6% 3 Year 26.8% 5 Year 20.5% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Data below for SBI Healthcare Opportunities Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 8. TATA India Pharma & Healthcare Fund
TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (14 Aug 25) ₹31.0352 ↓ -0.10 (-0.33 %) Net Assets (Cr) ₹1,282 on 30 Jun 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.47 Information Ratio 0.73 Alpha Ratio 2.42 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Aug 25 Duration Returns 1 Month 2.6% 3 Month 6.7% 6 Month 8.5% 1 Year 4.8% 3 Year 23.8% 5 Year 19.1% 10 Year 15 Year Since launch 12.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Data below for TATA India Pharma & Healthcare Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 9. IDBI Small Cap Fund
IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (14 Aug 25) ₹29.1101 ↓ -0.08 (-0.27 %) Net Assets (Cr) ₹605 on 30 Jun 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio -0.27 Information Ratio -0.92 Alpha Ratio -7.27 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for IDBI Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Aug 25 Duration Returns 1 Month -5.7% 3 Month 2.8% 6 Month 2.9% 1 Year -8.4% 3 Year 17.3% 5 Year 28.1% 10 Year 15 Year Since launch 14.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 40% 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Data below for IDBI Small Cap Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 10. Bandhan Infrastructure Fund
Bandhan Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (14 Aug 25) ₹48.965 ↓ -0.41 (-0.84 %) Net Assets (Cr) ₹1,749 on 30 Jun 25 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.33 Sharpe Ratio -0.3 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Bandhan Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 Aug 25 Duration Returns 1 Month -3.6% 3 Month 2.3% 6 Month 11.7% 1 Year -10.1% 3 Year 27.7% 5 Year 32.5% 10 Year 15 Year Since launch 11.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for Bandhan Infrastructure Fund
Name Since Tenure Data below for Bandhan Infrastructure Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity
یہاں فراہم کردہ معلومات کو درست بنانے کے لئے تمام کوششیں کی گئیں ہیں۔ تاہم ، اعداد و شمار کی درستگی کے بارے میں کوئی ضمانت نہیں دی گئی ہے۔ براہ کرم کوئی سرمایہ کاری کرنے سے پہلے اسکیم سے متعلق معلومات کے دستاویز کی تصدیق کریں۔
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved
Research Highlights for Motilal Oswal Midcap 30 Fund